Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Carcinoma, Non-Small-Cell Lung (approved 2021)
Anxiety (Phase 2)
Breast Neoplasms (Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Colitis, Ulcerative (Phase 1)
Colorectal Neoplasms (Phase 1/Phase 2)
Depression (Phase 1)
Depressive Disorder, Major (Phase 2)
Esophageal Neoplasms (Phase 2)
Head and Neck Neoplasms (Phase 1)
Lung Neoplasms (Phase 1/Phase 2)
Neoplasms (Phase 1)
Obesity (Early Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Salivary Gland Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue